How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share

被引:4
作者
Cai, Wenfeng [1 ]
Yang, Zifeng [2 ,3 ,4 ,5 ]
Liang, Jingyi [2 ,3 ,6 ]
Lin, Zhengshi [7 ]
Ma, Yu [1 ]
Chen, Chun [1 ]
Li, Yan [6 ]
Li, Yongming [2 ,3 ]
Mai, Zhitong [2 ,3 ,4 ]
Mai, Kailin [2 ,3 ]
Kong, Xuetao [2 ]
Liang, Xingyi [8 ]
Li, Qianying [2 ]
Tu, Chuanmeizi [2 ,3 ]
Chen, Canxiong [2 ]
Hon, Chitin [6 ]
Qin, Pengzhe [1 ]
Li, Ke [1 ]
Li, Xiaoning [1 ]
Miao, Yutian [1 ]
Liu, Xuexing [1 ]
Guan, Wenda [2 ,3 ]
Zeng, Zhiqi [2 ,3 ]
Qiu, Wanli [1 ]
He, Wei [6 ]
Zhang, Lin [7 ]
Yang, Zhicong [1 ]
Zhong, Nanshan [2 ,3 ]
机构
[1] Guangzhou Med Univ, Inst Publ Hlth, Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
[2] First Affiliated Hosp Guangzhou Med Univ, Guangzhou Inst Resp Hlth, Natl Ctr Resp Med, State Key Lab Resp Dis & Natl Clin Res Ctr Resp Di, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Lab, Bio-Isl, Guangzhou, Peoples R China
[4] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[5] Guangzhou Key Lab Clin Rapid Diag & Early Warning, Guangzhou, Peoples R China
[6] Macau Univ Sci & Technol, Macau Inst Syst Engn, Macau, Peoples R China
[7] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
[8] Shunde Urban & Rural Planning Informat Res Ctr, Foshan, Guangdong, Peoples R China
关键词
COVID-19; public health; control measure; epidemiological investigation; health code;
D O I
10.3389/fpubh.2022.979063
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
IntroductionSARS-CoV-2 has ravaged the world and undergone multiple mutations during the course of the COVID-19 pandemic. On 7 April 2022, an epidemic caused by SARS-CoV-2 Omicron (BA.2) variant broke out in Guangzhou, China, one of the largest transportation and logistical hubs of the country. MethodsTo fast curtained the Omicron epidemic, based on the routine surveillance on the risk population of SARS-CoV-2 infection, we identify key places of the epidemic and implement enhanced control measures against Omicron. ResultsTransmission characteristics of the Omicron variant were analyzed for 273 confirmed cases, and key places involved in this epidemic were fully presented. The median incubation time and the generation time were 3 days, and the reproduction number Rt was sharply increased with a peak of 4.20 within 2 days. We tried an all-out effort to tackle the epidemic in key places, and the proportion of confirmed cases increased from 61.17% at Stage 2 to 88.89% at Stage 4. Through delimited risk area management, 99 cases were found, and the cases were isolated in advance for 2.61 +/- 2.76 days in a lockdown zone, 0.44 +/- 1.08 days in a controlled zone, and 0.27 +/- 0.62 days in a precautionary zone. People assigned with yellow code accounted for 30.32% (84/277) of confirmed COVID-19 cases, and 83.33% of them were detected positive over 3 days since code assignment. For the districts outside the epicenter, the implementation duration of NPIs was much shorter compared with the Delta epidemic last year. ConclusionBy blocking out transmission risks and adjusting measures to local epidemic conditions through the all-out effort to tackle the epidemic in key places, by delimiting risk area management, and by conducting health code management of the at-risk population, the Omicron epidemic could be contained quickly.
引用
收藏
页数:14
相关论文
共 22 条
  • [1] Boarman A., 2021, Omicron is the dominant COVID variant for two reasons
  • [2] Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
    Brandal, Lin T.
    MacDonald, Emily
    Veneti, Lamprini
    Ravlo, Tine
    Lange, Heidi
    Naseer, Umaer
    Feruglio, Siri
    Bragstad, Karoline
    Hungnes, Olav
    Odeskaug, Liz E.
    Hagen, Frode
    Hanch-Hansen, Kristian E.
    Lind, Andreas
    Watle, Sara Viksmoen
    Taxt, Arne M.
    Johansen, Mia
    Vold, Line
    Aavitsland, Preben
    Nygard, Karin
    Madslien, Elisabeth H.
    [J]. EUROSURVEILLANCE, 2021, 26 (50)
  • [3] Omicron variant and booster COVID-19 vaccines
    Burki, Talha Khan
    [J]. LANCET RESPIRATORY MEDICINE, 2022, 10 (02) : E17 - E17
  • [4] Commission GMH, 2022, GUANGZH HAD REC 54 3
  • [5] SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
    Dejnirattisai, Wanwisa
    Huo, Jiandong
    Zhou, Daming
    Zahradnik, Jiri
    Supasa, Piyada
    Liu, Chang
    Duyvesteyn, Helen M. E.
    Ginn, Helen M.
    Mentzer, Alexander J.
    Tuekprakhon, Aekkachai
    Nutalai, Rungtiwa
    Wang, Beibei
    Dijokaite, Aiste
    Khan, Suman
    Avinoam, Ori
    Bahar, Mohammad
    Skelly, Donal
    Adele, Sandra
    Johnson, Sile Ann
    Amini, Ali
    Ritter, Thomas G.
    Mason, Chris
    Dold, Christina
    Pan, Daniel
    Assadi, Sara
    Bellass, Adam
    Omo-Dare, Nicola
    Koeckerling, David
    Flaxman, Amy
    Jenkin, Daniel
    Aley, Parvinder K.
    Voysey, Merryn
    Clemens, Sue Ann Costa
    Naveca, Felipe Gomes
    Nascimento, Valdinete
    Nascimento, Fernanda
    da Costa, Cristiano Fernandes
    Resende, Paola Cristina
    Pauvolid-Correa, Alex
    Siqueira, Marilda M.
    Baillie, Vicky
    Serafin, Natali
    Kwatra, Gaurav
    Da Silva, Kelly
    Madhi, Shabir A.
    Nunes, Marta C.
    Malik, Tariq
    Openshaw, Peter J. M.
    Baillie, J. Kenneth
    Semple, Malcolm G.
    [J]. CELL, 2022, 185 (03) : 467 - +
  • [6] Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19
    Faust, Jeremy Samuel
    Du, Chengan
    Liang, Chenxue
    Mayes, Katherine Dickerson
    Renton, Benjamin
    Panthagani, Kristen
    Krumholz, Harlan M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (01): : 74 - 76
  • [7] Gov.uk, 2022, COVID 19 RESP LIV CO
  • [8] Complementary and alternative medicine during COVID-19 pandemic: What we have done
    Ling, Chang-quan
    [J]. JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2022, 20 (01): : 1 - 3
  • [9] The Dynamic COVID-Zero Strategy in China
    Liu, Jue
    Liu, Min
    Liang, Wannian
    [J]. CHINA CDC WEEKLY, 2022, 4 (04): : 74 - 75
  • [10] Crucial control measures to contain China's first Delta variant outbreak
    Luo, Lei
    Yang, Zifeng
    Liang, Jingyi
    Ma, Yu
    Wang, Hui
    Hon, Chitin
    Jiang, Mei
    Lin, Zhengshi
    Guan, Wenda
    Mai, Zhitong
    Li, Yongming
    Mai, Kailin
    Zeng, Zhiqi
    Tu, Chuanmeizi
    Song, Jian
    Liu, Bin
    Liu, Yong
    He, Jianfeng
    Li, Huiyuan
    Li, Bosheng
    Dong, Hang
    Miao, Yutian
    Fan, Shujun
    Fan, Lirui
    Liang, Xingyi
    Li, Ke
    Chen, Chun
    Deng, Huihong
    Yang, Zhicong
    Zhong, Nanshan
    [J]. NATIONAL SCIENCE REVIEW, 2022, 9 (04)